Headquartered in San Diego, Aspen Neuroscience, Inc. is a development stage, private biotechnology company focused on personalised cell therapies. Aspen Neuroscience leverages stem cell biology and genomics to provide the world’s first autologous induced pluripotent stem cell (iPSC)-derived neuron replacement therapy for Parkinson's disease.